One problem: There may be warnings about cardiac and other side effects on the drug's label, although Iannini thinks these worries have been largely dispelled.
In January, Pfizer and the FDA added concerns about those side effects to the drug's label, which serves as a guide for doctors and the basis for claims in advertising.